title: Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys.
abstract: Prenatal discovery of fetal bilateral hyperechogenic kidneys is very stressful for pregnant women and their family, and accurate diagnosis of the cause of the moderate forms of this pathology is very difficult. Hepatocyte nuclear factor-1beta that is encoded by the TCF2 gene is involved in the embryonic development of the kidneys. Sixty-two pregnancies with fetal bilateral hyperechogenic kidneys including 25 fetuses with inaccurate diagnosis were studied. TCF2 gene anomalies were detected in 18 (29%) of these 62 patients, and 15 of these 18 patients presented a complete heterozygous deletion of the TCF2 gene. Family screening revealed de novo TCF2 anomalies in more than half of the patients. TCF2 anomalies were associated with normal amniotic fluid volume and normal-sized kidneys between -2 and +2 SD in all patients except for two sisters. Antenatal cysts were detected in 11 of 18 patients, unilaterally in eight of 11. After birth, cysts appeared during the first year (17 of 18), and in patients with antenatal cysts, the number increased and developed bilaterally with decreased renal growth. In these 18 patients, the GFR decreased with longer follow-up and was lower in patients with solitary functioning dysplastic kidney. Heterozygous deletion of the TCF2 gene is an important cause of fetal hyperechogenic kidneys in this study and showed to be linked with early disease expression. The renal phenotype and the postnatal evolution were extremely variable and need a prospective long-term follow-up. Extrarenal manifestations are frequent in TCF2-linked pathologies. Therefore, prenatal counseling and follow-up should be multidisciplinary.
authors.affiliation: Inserm, U858, BP 84225, F-3142, Paris, France. decramer.s@chu-toulouse.fr
authors.forename: Stéphane
authors.initials: S
authors.lastname: Decramer
authors.forename: Olivier
authors.initials: O
authors.lastname: Parant
authors.forename: Sandrine
authors.initials: S
authors.lastname: Beaufils
authors.forename: Séverine
authors.initials: S
authors.lastname: Clauin
authors.forename: Cécile
authors.initials: C
authors.lastname: Guillou
authors.forename: Sylvie
authors.initials: S
authors.lastname: Kessler
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Aziza
authors.forename: Flavio
authors.initials: F
authors.lastname: Bandin
authors.forename: Joost P
authors.initials: JP
authors.lastname: Schanstra
authors.forename: Christine
authors.initials: C
authors.lastname: Bellanné-Chantelot
mesh_terms: D000025:Abortion, Eugenic; D005260:Female; D005315:Fetal Diseases / Q000000981:diagnostic imaging / Q000235:genetics*; D017353:Gene Deletion; D005919:Glomerular Filtration Rate; D051539:Hepatocyte Nuclear Factor 1-beta / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D052177:Kidney Diseases, Cystic / Q000150:complications / Q000000981:diagnostic imaging / Q000235:genetics*; D008297:Male; D016104:Oligohydramnios / Q000209:etiology; D010290:Parents; D010641:Phenotype; D011247:Pregnancy; D016216:Ultrasonography, Prenatal
chemical_list: C496495:HNF1B protein, human; D051539:Hepatocyte Nuclear Factor 1-beta